Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Dr. Xiangxiang Zheng, Jiangsu Province Hospital, China

Dr. Xiangxiang Zheng, a dedicated cardiac surgeon at Jiangsu Provincial People’s Hospital since 2008, specializes in minimally invasive treatments for heart valve diseases and stem cell therapy for myocardial infarction. With a PhD and over 300 cardiac surgeries performed annually, he is at the forefront of cardiovascular innovation. His notable publications include research on engineering extracellular vesicles for diagnosis and therapy, and comparing surgical techniques for atrial septal defect repair. Dr. Zheng’s work significantly contributes to advancing surgical practices and improving patient outcomes. He is 42 years old and married. ❤️👨‍⚕️📚

 

Publication profile

Scopus


Professional Experience

Since 2008, Dr. Xiangxiang Zheng has been an esteemed cardiac surgeon in the Department of Cardiovascular Surgery at Jiangsu Provincial People’s Hospital. With over 300 cardiac surgeries performed annually, he has established himself as a leader in the field. Dr. Zheng specializes in minimally invasive treatments for heart valve diseases, which significantly reduce recovery time and improve patient outcomes. His expertise also extends to stem cell therapy for myocardial infarction, where he employs innovative techniques to enhance heart repair and regeneration. Dr. Zheng’s dedication to advancing cardiovascular care is evident through his hands-on surgical practice and commitment to exploring new methodologies in cardiac surgery. He continuously strives to improve surgical techniques and patient safety, making a lasting impact on the lives of those he treats. His contributions not only elevate the standard of care in his department but also serve as an inspiration to his colleagues and the medical community. 🌟👨‍⚕️📈

 

Research Focus

Dr. Xiangxiang Zheng’s research primarily focuses on cardiovascular surgery, particularly in innovative surgical techniques and therapies for heart diseases. His work emphasizes minimally invasive procedures, such as thoracoscopic surgeries for atrial septal defect repair, as well as advanced myocardial protection strategies during complex cardiac surgeries. Additionally, Dr. Zheng explores stem cell therapy and the engineering of extracellular vesicles for therapeutic applications, enhancing diagnosis and treatment methods in cardiology. His research also delves into the physiological impacts of surgical interventions on heart function and the progression of pulmonary arterial hypertension, contributing significantly to the field of cardiovascular medicine. 🏥📚✨

 

Publication Top Notes

  • Engineering extracellular vesicles for diagnosis and therapy 🧬
    Fei, Z., Zheng, J., Zheng, X., Ren, H., Liu, G.
    Trends in Pharmacological Sciences, 2024.
    Cited by: 0
  • The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats 🐭
    Liu, W., Men, C., Liu, Z., Zhang, L., Zheng, X.
    Journal of Physiological Investigation, 2024, 67(4), pp. 207-214.
    Cited by: 0
  • Triport Periareolar Thoracoscopic Surgery versus Right Minithoracotomy for Repairing Atrial Septal Defect in Adults 💔
    Zheng, X.-X., Wang, Z.-Y., Ma, L.-Y., Qin, J.-W., Shao, Y.-F.
    Interactive Cardiovascular and Thoracic Surgery, 2021, 32(2), pp. 313-318.
    Cited by: 5
  • Comparison of Myocardial Protection Effect between Del Nido Cardioplegia and Cold Blood Cardioplegia in Complex Cardiac Surgery 💉
    Jiao, S.-Y., Liu, L., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2020, 33(6), pp. 807-810.
    Cited by: 0
  • Myocardial Protective Effect of Three Cardioplegia in Adult Valve Replacement 💗
    Liu, H., Jiao, S.-Y., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2019, 32(6), pp. 775-778.
    Cited by: 1
  • Bilateral Superior Cervical Ganglionectomy Attenuates the Progression of β-Aminopropionitrile-induced Aortic Dissection in Rats 🧪
    Liu, H., Zheng, X., Zhang, L., Shao, Y., Zhang, S.
    Life Sciences, 2018, 193, pp. 200-206.
    Cited by: 5
  • Cardiac Autotransplantation for Repair of Left Ventricular Rupture after Mitral Valve Replacement 🏥
    Ni, B., Zheng, X., Zhang, S., Shao, Y.
    Interactive Cardiovascular and Thoracic Surgery, 2017, 25(1), pp. 150-152.
    Cited by: 3
  • Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma 🔬
    Hu, H.-B., Jie, H.-Y., Zheng, X.-X.
    Cellular Physiology and Biochemistry, 2016, 40(1-2), pp. 117-125.
    Cited by: 68
  • High Expression of LncRNA PVT1 Promotes Invasion by Inducing Epithelial-to-Mesenchymal Transition in Esophageal Cancer 🚀
    Zheng, X., Hu, H., Li, S.
    Oncology Letters, 2016, 12(4), pp. 2357-2362.
    Cited by: 85
  • Myxoid Fibrosarcoma of the Left Atrium and Ventricle in Pregnancy 👶❤️
    Zhang, W., Zheng, X., Ni, B., Shao, Y., Zhang, S.
    Annals of Thoracic Surgery, 2014, 98(5), pp. 1818-1819.
    Cited by: 3

David Song | Cardiovascular Disease | Excellence in Research

Posted on by ScienceFather

Dr. DavidSong | Cardiovascular Disease | Excellence in Research

Dr. DavidSong, Icahn School of Medicine at Mount Sinai Elmhurst, United States

Dr. David Song is a dedicated cardiologist with extensive medical training and a passion for education and research. He earned his Doctorate of Osteopathic Medicine from Rowan University and completed his Internal Medicine Residency at Icahn School of Medicine. Dr. Song’s accolades include awards for teaching, research, and professionalism. As an Executive Chief Resident, he demonstrated leadership at ISMMS/Elmhurst. Beyond medicine, Dr. Song is a Black Belt in Korean Kumdo and has a history of community service. His commitment extends to mentoring, tutoring, and various leadership roles. 🩺🏆📚

Publication Profile:

Scopus 

Orcid

Education:

Dr. David Song’s academic journey reflects a profound commitment to medical excellence. Beginning with a Bachelor of Science in Neuroscience from Stony Brook University, where he graduated with honors, Magna Cum Laude, Dr. Song continued to Rowan University for his Doctorate of Osteopathic Medicine. He further honed his skills through an Internal Medicine Residency at Icahn School of Medicine, followed by a Chief Residency. Currently, he is pursuing a Clinical Fellowship in Cardiovascular Disease at New York Presbyterian/Queens. Dr. Song’s educational odyssey embodies a relentless pursuit of knowledge and expertise in cardiovascular health. 🩺

Honors and Awards:

Dr. David Song stands as a beacon of academic excellence, adorned with numerous accolades throughout his educational journey. His achievements include being recognized as Internal Medicine PGY-3 Resident Teacher and Resident of the Year at Icahn School of Medicine. Dr. Song’s dedication to research earned him the First Place Research Poster Award and membership in the prestigious Alpha Omega Alpha Honor Medical Society. Notably, he received the Doximity Most Cited Research and Top Published Research Awards, showcasing his impact in the medical field. Beyond academics, his commitment to community service is exemplified by scholarships, leadership awards, and extensive involvement in medical missions. 🏆👨‍⚕️

Work Experience:

Dr. David Song’s multifaceted career includes serving as the Executive Chief Resident at ISMMS/Elmhurst, showcasing his leadership in medical education. His commitment extends to mentorship through the Central Academic Assistance Program at Central Presbyterian Church, where he imparted knowledge to high school students. Dr. Song’s research expertise shines through his role as a Clinical Research Coordinator at Penn Medicine, where he contributed to therapeutic lipid-lowering drug development. His dedication to education continued as a Peer Tutor at Rowan SOM and Head Instructor at Plainview Summer School. Beyond academia, Dr. Song’s analytical skills were honed as an Analytical Chemist, and he contributed significantly as a Research Assistant at Stony Brook University. 🌐👨‍🏫

Research Focus:

Dr. David Song, a distinguished researcher in cardiovascular medicine, has made significant contributions to the field through a prolific body of work. His research focuses on diverse topics, ranging from the intricacies of mitral regurgitation in heart failure to meta-analyses comparing different percutaneous coronary interventions. Dr. Song collaborates with esteemed colleagues, consistently publishing in reputable journals such as Radiology Case Reports and The American Journal of Cardiology. His dedication to unraveling complex medical scenarios, including the impact of COVID-19 on cardiovascular outcomes, showcases a commitment to advancing medical knowledge. 📊🔬

Publication Top Notes:

Ortner syndrome as a presenting symptom of severe chronic mitral regurgitation in heart failure: A case report

Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis

A case report of multiple abscesses caused by Streptococcus intermedius

RETRACTED: Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: A meta-analysis

Too much of a good thing: Immune reconstitution inflammatory syndrome in a patient with Still’s disease

Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis

A rare case of delayed anaplasma phagocytophilum-induced pancytopenia: A diagnostic conundrum

Meta-Analysis Comparing Gender-Based Cardiovascular Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention

Curing the incurable: A case of refractory vasospastic angina